Michael Breen
Board Member
GT Biopharma, Inc. (GTBP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Breen
Michael Breen is recorded as CEO and Board Member at GT Biopharma, Inc. (GTBP). GT Biopharma, Inc. reported in an 8-K filed May 5, 2025 that Michael Breen was appointed Chief Executive Officer, effective April 29, 2025. The proxy statement of GT Biopharma, Inc. reports total compensation of $1,727,646 for Michael Breen in fiscal 2025, including a base salary of $641,020. Disclosed compensation is on record for 6 fiscal years.
“On April 29, 2025, GT Biopharma, Inc. (the "Company") appointed Michael Breen as its Chief Executive Officer for a two-year term, effective as of April 29, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-01-13–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at GT Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Anthony Cataldo CEO
- Dr. Gregory Berk CEO
- Bruce Wendel Chairman
- Alan L. Urban CFO, Board Member
- Alan Urban CFO
- Dr. Gavin Choy CFO
- Michael Handelman CFO
- Andrew Ritter Board Member
- Charles J. Casamento Board Member
- David C. Mun-Gavin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | GT Biopharma, Inc. (GTBP) | Chairman, Chief Executive Officer, and President | $641,020 | $1,727,646 |
| 2024 | GT Biopharma, Inc. (GTBP) | Chairman, Chief Executive Officer, and President | $556,200 | $1,186,972 |
| 2023 | GT Biopharma, Inc. (GTBP) | Executive Chairman of the Board of Directors and Interim Chief Executive Officer | $556,200 | $1,525,834 |
| 2022 | GT Biopharma, Inc. (GTBP) | Executive Chairman of the Board of Directors and Interim Chief Executive Officer | $492,500 | $1,892,293 |
| 2021 | GT Biopharma, Inc. (GTBP) | Executive Chairman of the Board of Directors and Interim Chief Executive Officer | $62,784 | $2,827,703 |
| 2020 | GT Biopharma, Inc. (GTBP) | Executive Chairman of the Board of Directors | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.